Withaferin A suppresses the up-regulation of acetyl-coA carboxylase 1 and skin tumor formation in a skin carcinogenesis mouse model

Wenjuan Li, Chunjing Zhang, Hongyan Du, Vincent Huang, Brandi Sun, John P. Harris, Quitin Richardson, Xinggui Shen, Rong Jin, Guohong Li, Christopher G. Kevil, Xin Gu, Runhua Shi, Yunfeng Zhao

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Withaferin A (WA), a natural product derived from Withania somnifera, has been used in traditional oriental medicines to treat neurological disorders. Recent studies have demonstrated that this compound may have a potential for cancer treatment and a clinical trial has been launched to test WA in treating melanoma. Herein, WA's chemopreventive potential was tested in a chemically-induced skin carcinogenesis mouse model. Pathological examinations revealed that WA significantly suppressed skin tumor formation. Morphological observations of the skin tissues suggest that WA suppressed cell proliferation rather than inducing apoptosis during skin carcinogenesis. Antibody Micro array analysis demonstrated that WA blocked carcinogen-induced up-regulation of acetyl-CoA carboxylase 1 (ACC1), which was further confirmed in a skin cell transformation model. Overexpression of ACC1 promoted whereas knockdown of ACC1 suppressed anchorage-independent growth and oncogene activation of transformable skin cells. Further studies demonstrated that WA inhibited tumor promotor-induced ACC1 gene transcription by suppressing the activation of activator protein 1. In melanoma cells, WA was also able to suppress the expression levels of ACC1. Finally, results using human skin cancer tissues confirmed the up-regulation of ACC1 in tumors than adjacent normal tissues. In summary, our results suggest that withaferin A may have a potential in chemoprevention and ACC1 may serve as a critical target of WA.

Original languageEnglish (US)
Pages (from-to)1739-1746
Number of pages8
JournalMolecular Carcinogenesis
Volume55
Issue number11
DOIs
StatePublished - Nov 1 2016

Fingerprint

Acetyl-CoA Carboxylase
Carcinogenesis
Up-Regulation
Skin
Neoplasms
Melanoma
Withania
East Asian Traditional Medicine
withaferin A
Transcription Factor AP-1
Chemoprevention
Skin Neoplasms
Nervous System Diseases
Biological Products
Oncogenes
Carcinogens
Transcriptional Activation
Cell Proliferation
Clinical Trials
Apoptosis

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cancer Research

Cite this

Li, Wenjuan ; Zhang, Chunjing ; Du, Hongyan ; Huang, Vincent ; Sun, Brandi ; Harris, John P. ; Richardson, Quitin ; Shen, Xinggui ; Jin, Rong ; Li, Guohong ; Kevil, Christopher G. ; Gu, Xin ; Shi, Runhua ; Zhao, Yunfeng. / Withaferin A suppresses the up-regulation of acetyl-coA carboxylase 1 and skin tumor formation in a skin carcinogenesis mouse model. In: Molecular Carcinogenesis. 2016 ; Vol. 55, No. 11. pp. 1739-1746.
@article{ebf15ce94b6f460f9d12f31eaf6fedcd,
title = "Withaferin A suppresses the up-regulation of acetyl-coA carboxylase 1 and skin tumor formation in a skin carcinogenesis mouse model",
abstract = "Withaferin A (WA), a natural product derived from Withania somnifera, has been used in traditional oriental medicines to treat neurological disorders. Recent studies have demonstrated that this compound may have a potential for cancer treatment and a clinical trial has been launched to test WA in treating melanoma. Herein, WA's chemopreventive potential was tested in a chemically-induced skin carcinogenesis mouse model. Pathological examinations revealed that WA significantly suppressed skin tumor formation. Morphological observations of the skin tissues suggest that WA suppressed cell proliferation rather than inducing apoptosis during skin carcinogenesis. Antibody Micro array analysis demonstrated that WA blocked carcinogen-induced up-regulation of acetyl-CoA carboxylase 1 (ACC1), which was further confirmed in a skin cell transformation model. Overexpression of ACC1 promoted whereas knockdown of ACC1 suppressed anchorage-independent growth and oncogene activation of transformable skin cells. Further studies demonstrated that WA inhibited tumor promotor-induced ACC1 gene transcription by suppressing the activation of activator protein 1. In melanoma cells, WA was also able to suppress the expression levels of ACC1. Finally, results using human skin cancer tissues confirmed the up-regulation of ACC1 in tumors than adjacent normal tissues. In summary, our results suggest that withaferin A may have a potential in chemoprevention and ACC1 may serve as a critical target of WA.",
author = "Wenjuan Li and Chunjing Zhang and Hongyan Du and Vincent Huang and Brandi Sun and Harris, {John P.} and Quitin Richardson and Xinggui Shen and Rong Jin and Guohong Li and Kevil, {Christopher G.} and Xin Gu and Runhua Shi and Yunfeng Zhao",
year = "2016",
month = "11",
day = "1",
doi = "10.1002/mc.22423",
language = "English (US)",
volume = "55",
pages = "1739--1746",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "11",

}

Li, W, Zhang, C, Du, H, Huang, V, Sun, B, Harris, JP, Richardson, Q, Shen, X, Jin, R, Li, G, Kevil, CG, Gu, X, Shi, R & Zhao, Y 2016, 'Withaferin A suppresses the up-regulation of acetyl-coA carboxylase 1 and skin tumor formation in a skin carcinogenesis mouse model', Molecular Carcinogenesis, vol. 55, no. 11, pp. 1739-1746. https://doi.org/10.1002/mc.22423

Withaferin A suppresses the up-regulation of acetyl-coA carboxylase 1 and skin tumor formation in a skin carcinogenesis mouse model. / Li, Wenjuan; Zhang, Chunjing; Du, Hongyan; Huang, Vincent; Sun, Brandi; Harris, John P.; Richardson, Quitin; Shen, Xinggui; Jin, Rong; Li, Guohong; Kevil, Christopher G.; Gu, Xin; Shi, Runhua; Zhao, Yunfeng.

In: Molecular Carcinogenesis, Vol. 55, No. 11, 01.11.2016, p. 1739-1746.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Withaferin A suppresses the up-regulation of acetyl-coA carboxylase 1 and skin tumor formation in a skin carcinogenesis mouse model

AU - Li, Wenjuan

AU - Zhang, Chunjing

AU - Du, Hongyan

AU - Huang, Vincent

AU - Sun, Brandi

AU - Harris, John P.

AU - Richardson, Quitin

AU - Shen, Xinggui

AU - Jin, Rong

AU - Li, Guohong

AU - Kevil, Christopher G.

AU - Gu, Xin

AU - Shi, Runhua

AU - Zhao, Yunfeng

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Withaferin A (WA), a natural product derived from Withania somnifera, has been used in traditional oriental medicines to treat neurological disorders. Recent studies have demonstrated that this compound may have a potential for cancer treatment and a clinical trial has been launched to test WA in treating melanoma. Herein, WA's chemopreventive potential was tested in a chemically-induced skin carcinogenesis mouse model. Pathological examinations revealed that WA significantly suppressed skin tumor formation. Morphological observations of the skin tissues suggest that WA suppressed cell proliferation rather than inducing apoptosis during skin carcinogenesis. Antibody Micro array analysis demonstrated that WA blocked carcinogen-induced up-regulation of acetyl-CoA carboxylase 1 (ACC1), which was further confirmed in a skin cell transformation model. Overexpression of ACC1 promoted whereas knockdown of ACC1 suppressed anchorage-independent growth and oncogene activation of transformable skin cells. Further studies demonstrated that WA inhibited tumor promotor-induced ACC1 gene transcription by suppressing the activation of activator protein 1. In melanoma cells, WA was also able to suppress the expression levels of ACC1. Finally, results using human skin cancer tissues confirmed the up-regulation of ACC1 in tumors than adjacent normal tissues. In summary, our results suggest that withaferin A may have a potential in chemoprevention and ACC1 may serve as a critical target of WA.

AB - Withaferin A (WA), a natural product derived from Withania somnifera, has been used in traditional oriental medicines to treat neurological disorders. Recent studies have demonstrated that this compound may have a potential for cancer treatment and a clinical trial has been launched to test WA in treating melanoma. Herein, WA's chemopreventive potential was tested in a chemically-induced skin carcinogenesis mouse model. Pathological examinations revealed that WA significantly suppressed skin tumor formation. Morphological observations of the skin tissues suggest that WA suppressed cell proliferation rather than inducing apoptosis during skin carcinogenesis. Antibody Micro array analysis demonstrated that WA blocked carcinogen-induced up-regulation of acetyl-CoA carboxylase 1 (ACC1), which was further confirmed in a skin cell transformation model. Overexpression of ACC1 promoted whereas knockdown of ACC1 suppressed anchorage-independent growth and oncogene activation of transformable skin cells. Further studies demonstrated that WA inhibited tumor promotor-induced ACC1 gene transcription by suppressing the activation of activator protein 1. In melanoma cells, WA was also able to suppress the expression levels of ACC1. Finally, results using human skin cancer tissues confirmed the up-regulation of ACC1 in tumors than adjacent normal tissues. In summary, our results suggest that withaferin A may have a potential in chemoprevention and ACC1 may serve as a critical target of WA.

UR - http://www.scopus.com/inward/record.url?scp=84989278724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989278724&partnerID=8YFLogxK

U2 - 10.1002/mc.22423

DO - 10.1002/mc.22423

M3 - Article

VL - 55

SP - 1739

EP - 1746

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 11

ER -